Research now show that CAT [19,21,54,55], SOD [23,24,56] and GSH-Px [16,54,56] are strongly down-regulated in Hepatocellular carcinoma, the putative explanation being likely, again, a genetic reprogramming in favor of high proliferative capacity of the cancer cells. This evidence concerns the gene SOD1 and cancer.